|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"shih jin yuan"
Showing items 41-50 of 208 (21 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2021-05-05T05:31:04Z |
An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan
|
Shang-Gin Wu;Chiang, Chi-Lu;Liu, Chien-Ying;Wang, Chin-Chou;Su, Po-Lan;Hsia, Te-Chun;Shih, Jin-Yuan;Chang, Gee-Chen; SHANG-GIN WU; Chiang, Chi-Lu; Liu, Chien-Ying; Wang, Chin-Chou; Su, Po-Lan; Hsia, Te-Chun; Shih, Jin-Yuan; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-05-05T05:28:58Z |
The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation
|
Shang-Gin Wu;Yu, Chong-Jen;Yang, James Chih-Hsin;Shih, Jin-Yuan; SHANG-GIN WU; Yu, Chong-Jen; Yang, James Chih-Hsin; Shih, Jin-Yuan |
| 臺大學術典藏 |
2021-05-04T01:36:15Z |
Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer
|
Hsu, Chia-Lin; Tsai, Tzu-Hsiu; Huang, Chun-Kai; Yang, Ching-Yao; WEI-YU LIAO; Ho, Chao-Chi; Ruan, Sheng-Yuan; Chen, Kuan-Yu; Shih, Jin-Yuan; Yang, Pan-Chyr |
| 臺大學術典藏 |
2021-05-02T02:58:15Z |
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process
|
Wang, Hsin-Yi; Liu, Yi-Nan; Wu, Shang-Gin; Hsu, Chia-Lang; Chang, Tzu-Hua; Tsai, Meng-Feng; YEN-TING LIN; Shih, Jin-Yuan |
| 臺大學術典藏 |
2021-02-08T08:05:10Z |
Effect of beta-Blocker in Treatment-Naive Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs
|
JEN-CHUNG KO; CHIA-HAO CHANG; LIH-YU CHANG; Lee, Chih-Hsin ; Lee, Ming-Chia ; Zhang, Jun-Fu ; Wang, Jann-Yuan ; Shih, Jin-Yuan ; Yu, Chong-Jen |
| 臺大學術典藏 |
2019-12-19T08:05:13Z |
Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors
|
LIH-YU CHANG; Chang, Lih-Chyun; Lim, Chor-Kuan; Chen, Kuan-Yu; Shih, Jin-Yuan; Yu, Chong-Jen |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
|
Yang, James Chih-Hsin; Shih, Jin-Yuan;SHENG KAI LIANG;JEN-CHUNG KO; JEN-CHUNG KO; SHENG KAI LIANG; Yang, James Chih-Hsin; Shih, Jin-Yuan |
| 臺大學術典藏 |
2019-11-21T12:26:12Z |
Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: A case-control observational study
|
Yu, Chong Jen;Chen, Yung Hsuan;Shih, Jin Yuan;Chen, Yen Fu;Chen, Chung Yu; Chen, Chung Yu; Chen, Yen Fu; Shih, Jin Yuan; Chen, Yung Hsuan; Yu, Chong Jen |
| 臺大學術典藏 |
2018-09-10T15:38:24Z |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
楊志新;蘇剛毅;廖唯昱;余忠仁;何肇基;阮聖元;施金元; 楊志新;蘇剛毅;廖唯昱;余忠仁;何肇基;阮聖元;施金元; Chen, Li-Yang; Chen, Li-Yang; Chong-Jen Yu; Molina-Vila, Miguel A.; WEI-YU LIAO; KAI-LUN YU; Ruan, Sheng-Yuan; Ruan, Sheng-Yuan; Ruan, Sheng-Yuan; Su, Kang-Yi; Su, Kang-Yi; CHAO-CHI HO; KANG-YI SU; Liao, Wei-Yu; Liao, Wei-Yu; Yu, Kai-Lun; Yu, Kai-Lun; JIN-YUAN SHIH; Yu, Kai-Lun; Ho, Chao-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Shih, Jin-Yuan; Shih, Jin-Yuan; Yu, Chong-Jen; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, James Chih-Hsin; Rosell, Rafael; Rosell, Rafael; Yang, Pan-Chyr; Yang, Pan-Chyr; Yang, Pan-Chyr; Chen, Li-Yang;Molina-Vila, Miguel A.;Ruan, Sheng-Yuan;Su, Kang-Yi;Liao, Wei-Yu;Yu, Kai-Lun;Ho, Chao-Chi;Shih, Jin-Yuan;Yu, Chong-Jen;Yang, James Chih-Hsin;Rosell, Rafael;Yang, Pan-Chyr; Chen, L.-Y. and Molina-Vila, M.A. and Ruan, S.-Y. and Su, K.-Y. and Liao, W.-Y. and Yu, K.-L. and Ho, C.-C. and Shih, J.-Y. and Yu, C.-J. and Yang, J.C.H. and Rosell, R. and Yang, P.-C. |
| 臺大學術典藏 |
2018-09-10T15:37:45Z |
Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
|
Wu, Shang-Gin;Liu, Yi-Nan;Yu, Chong-Jen;Yang, Pan-Chyr;Shih, Jin-Yuan; Wu, S.-G. and Liu, Y.-N. and Yu, C.-J. and Yang, P.-C. and Shih, J.-Y.; 余忠仁;吳尚俊;施金元; Wu, Shang-Gin; Chong-Jen Yu; Wu, Shang-Gin; Liu, Yi-Nan; JIN-YUAN SHIH; Yu, Chong-Jen; Yu, Chong-Jen; Yang, Pan-Chyr; Yang, Pan-Chyr; Shih, Jin-Yuan; Shih, Jin-Yuan |
Showing items 41-50 of 208 (21 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
|
